| Literature DB >> 36133819 |
Sohaib Khatib1, Mansour Sobeh2, Latifa Bouissane1.
Abstract
Tetraclinis articulata (Vahl) Masters, commonly known as Sandarac tree and Araâr, is the only species representing the genus Tetraclinis Masters. The plant has been extensively used for medicinal, artistic, and ritual purposes since its first recorded use in 1800 B.C. Recently, a full range of ethnobotanical investigations has been undertaken to document the plant's empirical knowledge. They reported the use of different parts, such as leaves, stems, cones, bark, and roots, as part of folk healing practices to manage diabetes mellitus, hypertension, fever, stomach disorders, and diarrhea, among others. The phytochemical studies have identified at least 130 compounds from leaves, cones, resin, bark, and woods. These chemical constituents are categorized into phenolic acids, flavonoids and their derivatives, volatile compounds, phytosterols, and fatty acids, among others. Furthermore, they have strongly been correlated with the promising antimicrobial, antioxidant, neuroprotective, antiurolithiatic, anti-inflammatory, antidiabetic, and cytotoxic properties of the plant. Toxicological studies argued that the plant is quite safe and devoid of eventual toxicity; however, in-depth investigations are required to validate the safety of the plant. The remarkable antimicrobial and antioxidant potencies of various extracts from the plant against a wide range of foodborne pathogens support their possible use to increase the shelf life of foodstuffs in the food industry. Likewise, various plant-based extracts have been proven to exert substantial biocidal properties, making them potential alternatives to synthetic pesticides in agriculture. The present review provides an up-to-date comprehensive insight about the ethnobotanical uses of T. articulata, along with its phytochemistry and biological activities to furnish directions for further studies. We also discussed the biocidal potency of the plant and highlighted its usage to extend the shelf life of perishable foods.Entities:
Keywords: Tetraclinis articulata (Vahl) Masters; biocide; ethnopharmacology; phytochemistry; toxicity
Year: 2022 PMID: 36133819 PMCID: PMC9483659 DOI: 10.3389/fphar.2022.977726
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.988
FIGURE 1Flowchart of T. articulata studies inclusion and exclusion criteria.
Synonyms and common names of T. articulata (Vahl) Masters according to the World Flora Online (http://www.worldfloraonline.org/taxon/wfo-0000456325. Accessed on: 03 August 2022).
| Synonyms* | References | |
|---|---|---|
|
|
| |
|
| ||
|
| ||
|
| ||
|
| *Confidence level: III (High Confidence level) | |
|
| ||
|
| ||
|
| ||
|
| ||
|
| ||
| Arabic |
|
|
|
| ||
| Amazigh |
|
|
| French |
|
|
| English |
|
|
| Spanish |
|
|
FIGURE 2Different parts of T. articulata (Vahl) Masters (A) the whole plant; (B) Leaves; (C) Fruits (Pictures were taken in the region of Beni Mellal-khenifra, Morocco, 32⁰54′26.9″N 6⁰16′51.5″W) 2022©.
FIGURE 3Geographical distribution of T. articulata, 2022©.
FIGURE 4The most common preparation methods, routes of administration and used parts of T. articulata, as well as the number of ethnobotanical studies in each country.
Sum-up of the ethnobotanical uses of T. articulata.
| Vernacular names | Parts used | Ethno-preparations | Mode of administration | Ethnobotanical uses | References |
|---|---|---|---|---|---|
|
| |||||
|
| Nr | Fumigation | Nr | Antiseptic |
|
|
| Le, Sd | Decoction | Oral, inhalation | Cough, flu |
|
|
| Nr | Nr | Oral, topical | Respiratory tract and intestinal infections. Externally, it is used to scar the umbilical wounds of neonates |
|
|
| Le, Fr, AP | Infusion, Decoction, Cataplasm | Oral, topical | Tuberculosis, stomach disorders, diarrhea, cough, infection of the urinary tract, nausea, migraine, anxiety, and colon diseases |
|
|
| Le | Maceration | Oral | The leaves’ maceration is taken to treat diabetes mellitus |
|
|
| |||||
| Araâr | Le, St | Decoction | Oral | Antidiarrhea, hair care, digestive diseases, and as a natural vomiting agent |
|
| Azuka | Le | Decoction, Powder | Oral | Digestive disorders, gastric folds, abdominal pain and diarrhea |
|
|
| Le | Infusion | Oral | To treat diabetes mellitus, an infusion of the plant’s leaves is taken orally for a period of 1 week to 1 month |
|
| Azouka, Aârar | Le, Fr | Decoction, Powder, Infusion, Cataplasm | Oral, topical | Digestive, urinary, and respiratory disorders, circulatory, skeleton, and nervous problems |
|
| Azouka, | Le, Fr | Infusion | Oral | Carminative, asthma, cough, and digestive problems |
|
|
| Le | Powder, Cataplasm | Topical, oral | Poultice leaves are applied to the head to treat fevers, while powdered leaves are used to treat abdominal pains and colds |
|
|
| Le, Br | Decoction | Oral | Diabetes Mellitus |
|
|
| Le | Powder | Oral | Diabetes Mellitus |
|
|
| Sd, Le | Nr | Oral | Diabetes Mellitus, Hypertension |
|
|
| Le, WP, Fr | Decoction, Powder, Infusion | Topical, inhalation | Leaves, fruits, and the whole plant are crushed to obtain a powder, or subjected to decoction/infusion, then mixed with honey and alum and applied topically to treat rheumatism, foot, sciatic nerve, sprains, burns, pimples, and skin problems |
|
|
| Le, Fr | Infusion | Topical, oral | The infusion of leaves and fruits has been used as a carminative and to cure coughs, asthma, and digestive problems. The leaves of the plant are mixed with those of |
|
|
| Le | Cataplasm | Topical | Dermatological diseases such as eczema |
|
|
| Le | Decoction | Oral | Leaves decoction is blended with milk and used by local people as an analgesic agent, to treat rheumatic and stomach disorders |
|
|
| Le | Infusion, Fumigation | Oral, inhalation | Hypotensive agent, diabetes mellitus, and stomachache |
|
|
| Le | Powder | Topical | The leaves powder is sprinkled immediately on the burns |
|
| Araâr | Le | Powder | Topical | The leaves powder is sprinkled immediately on the burns |
|
|
| Le | Powder | Oral | Antihypertensive use |
|
|
| |||||
|
| Wd | Tar (The plant’s wood distillation) | Topical | A distilled dried wood-based cream is applied topically to treat parasitic diseases, inflamed wounds, and scabies in camels |
|
AbbreviationsLe, Leaves; Fr, Fruits; WP, whole plant, Sd, Seeds; St, Stem; AP, aerial parts; Br, Branch; Nr, Not reported.
Chemical composition of T. articulata EOs and extracts.
| Compound names | Plant organs | Characterization methods | References |
|---|---|---|---|
|
| |||
| Quercetin (quercetin-3- | Cones, Leaves | LC–DAD–ESI–MSn, UPLC-PDA-MS, GC–MS,HPLC |
|
| Rutin | |||
| (+)-Catechin | |||
| (−)-Epicatechin | |||
| Isoquercetin (quercetin-3- | |||
| Myricetin- | |||
| Myricetin-3- | |||
| Myricetin-3- | |||
| Myricetin-3- | |||
| Kaempferol-3- | |||
| Kaempferol-deoxyhexose | |||
| Cupressuflavone | |||
| Amentoflavone | |||
|
| |||
| Caffeic acid | Cones, Leaves | LC–MS, GC–MS |
|
| Vanillic acid | |||
| Rosmarinic acid | |||
| Chlorogenic acid | |||
| Syringic acid | |||
| Salicylic acid | |||
|
| |||
| | Leaves, cones, resin | GC–MS, RI |
|
|
| |||
|
| |||
|
| |||
| Thymol mono | |||
| β-Caryophyllene | |||
| Caryophyllene oxide | |||
| Isobornyl acetate | Leaves, resin | ||
| Limonene | |||
|
| |||
| Borneol | Leaves, bark | ||
| Carvacrol | |||
| | Bark, cones | ||
|
| |||
| Verbenone | |||
|
| |||
| Myrtenol | |||
| 4-Terpineol | Resin, bark | ||
| Totarol | Burl wood, resin | ||
| Bornyl acetate | Resin, cones | ||
| Myrtenal | Leaves, cones | ||
| | Leaves, Burl wood | ||
| 3-Tert-butyl-4-methoxyphenol | Burl wood | ||
| Cedrenol | |||
| Sclarene | |||
|
| |||
| Cedran-diol | |||
| | Bark | ||
|
| |||
| Thymylisobutyrate | |||
| Nerylisobutyrate | |||
| Carotol | |||
| Longifolene | |||
| Elemol | |||
| Humulene epoxide II | |||
| Atiserene | |||
| Fenchol | |||
| Cyclosativene | |||
| Camphor | Leaves | ||
|
| |||
| 1- | |||
|
| |||
| Sibirene | |||
|
| |||
|
| |||
| Valencene | |||
| Germacrene D | |||
| Myrcene | |||
| Campholenal | |||
| Isoledene | |||
| Cedrol | |||
| Cubenol | |||
| Caryophylladienol | |||
| Bourbonelol | |||
|
| |||
| Isoledene | |||
|
| |||
| Tricyclene | |||
|
| |||
|
| |||
| | Cones | ||
| 2,4-thujadiene | |||
| Linalool | |||
| α-campholenal | |||
| Pinocarvone | |||
| | Resin | ||
| Viridiflorene | |||
| Carvone | |||
|
| |||
| 1- | |||
|
| |||
| Dodecanoic acid | Trunk bark | GC-EI-MS, GC/MS |
|
| 2-Nonanol | |||
| 1-Hexadecene | |||
|
| |||
| n-Hexadecane | |||
|
| |||
| | Cones | CGC |
|
| Compesterol | |||
| Brassicasterol | |||
| Stigmasterol | |||
| Cholesterol | |||
| Δ-5-Avenasterol | |||
| Δ-7-Avenasterol | |||
| Δ-7-Stigmasterol | |||
|
| |||
| Sandaracopimaric acid | Sandarac Resin | GC-MS |
|
| Methylsandaracopimarate | |||
| Methyl pimarate | |||
| Sandaracopimarinol | |||
| 4- | |||
| Pimaric acid | |||
|
| |||
|
| |||
| Isopimaric acid | |||
| Pimara-7,15-dien-3-one | |||
| Laevopimaric acid | |||
|
| |||
| | Sandarac Resin | GC-MS |
|
|
| |||
| Manool | |||
| Totarol | |||
| Agathalic acid | |||
| Acetoxy agatholic acid | |||
| Agathic acid | |||
| Agatholic acid | |||
|
| |||
| Lipids content (6.66%) | Air-dried leaf | Kjeldahl method |
|
| Total nitrogen (0.07%) | |||
| Protein (0.44%) | |||
| Wax and Greases (6%) | |||
FIGURE 5Summary of the phytoconstituents from T. articulata by class of natural products (The percentage of each class was calculated based on the total number of chemical components).
The predicted organ toxicity and toxicological endpoints of phenolic compounds and the main volatile compounds using the ProTox-II server.
| Compounds | Molecular weight | Predicted LD50 (mg/kg) | Toxicity class | Organ toxicity (% probability) | Toxicity Endpoints (% probability) | |||
|---|---|---|---|---|---|---|---|---|
| Hepatotoxicity | Carcinogenicity | Immunotoxicity | Mutagenicity | Cytotoxicity | ||||
|
| ||||||||
| Gallic acid | 170.12 | 2000 | IV | Inactive (61) | Active (56) | Inactive (99) | Inactive (94) | Inactive (91) |
| Caffeic acid | 180.16 | 2,980 | V | Inactive (57) | Active (78) | Inactive (50) | Inactive (98) | Inactive (86) |
| Vanillic acid | 168.15 | 2000 | IV | Inactive (55) | Inactive (64) | Inactive (97) | Inactive (96) | Inactive (93) |
| Rosmarinic acid | 360.32 | 5,000 | V | Inactive (62) | Inactive (66) | Active (93) | Inactive (85) | Inactive (90) |
| Chlorogenic acid | 354.31 | 5,000 | V | Inactive (72) | Inactive (68) | Active (99) | Inactive (93) | Inactive (80) |
| Syringic acid | 198.17 | 1700 | IV | Inactive (58) | Inactive (70) | Inactive (97) | Inactive (93) | Inactive (97) |
| Salicylic acid | 138.12 | 1,034 | IV | Active (51) | Inactive (67) | Inactive (99) | Inactive (98) | Inactive (86) |
|
| ||||||||
| Quercetin | 302.24 | 159 | III | Inactive (69) | Active (68) | Inactive (87) | Active (51) | Inactive (99) |
| Isoquercetin | 464.38 | 5,000 | V | Inactive (82) | Inactive (85) | Active (66) | Inactive (76) | Inactive (69) |
| Rutin | 610.52 | 5,000 | V | Inactive (80) | Inactive (91) | Active (98) | Inactive (88) | Inactive (64) |
| (+)-Catechin | 290.27 | 10,000 | VI | Inactive (72) | Inactive (51) | Inactive (96) | Inactive (55) | Inactive (84) |
| (−)-Epicatechin | 290.27 | 10,000 | VI | Inactive (72) | Inactive (51) | Inactive (96) | Inactive (55) | Inactive (84) |
| Cupressuflavone | 538.46 | 3,919 | V | Inactive (76) | Inactive (69) | Inactive (92) | Inactive (71) | Inactive (98) |
| Amentoflavone | 538.46 | 3,919 | V | Inactive (76) | Inactive (69) | Active (51) | Inactive (71) | Inactive (98) |
| Myricetin-3- | 626.52 | 5,000 | V | Inactive (80) | Inactive (91) | Active (99) | Inactive (88) | Inactive (64) |
| Myricetin-3- | 470.3 | 5,000 | V | Inactive (82) | Inactive (85) | Active (79) | Inactive (76) | Inactive (79) |
| Kaempferol-3- | 432.38 | 5,000 | V | Inactive (73) | Active (50) | Active (92) | Inactive (71) | Inactive (93) |
|
| ||||||||
| Bornyl acetate | 196.29 | 3,100 | V | Inactive (58) | Inactive (62) | Inactive (94) | Inactive (94) | Inactive (67) |
| Camphor | 152.23 | 775 | IV | Inactive (72) | Inactive (68) | Inactive (96) | Inactive (94) | Inactive (61) |
|
| 136.23 | 3,700 | V | Inactive (86) | Inactive (60) | Inactive (99) | Inactive (93) | Inactive (75) |
Class I: fatal if consumed (LD50 ≤ 5); Class II: fatal if consumed (5 < LD50 ≤ 50); Class III: toxic if consumed (50 < LD50 ≤ 300); Class IV: harmful if consumed (300 < LD50 ≤ 2000); Class V: may be harmful if consumed (2000 < LD50 ≤ 5,000); Class VI: non-toxic (LD50 > 5,000).
FIGURE 6Summary of biological activities of T. articulata.
Summary of cytotoxic, neuroprotective, anti-inflammatory, and antioxidant potencies of various T. articulata extracts.
| Extract | Used method | Country | Key results | References |
|---|---|---|---|---|
|
| ||||
| Cytotoxic activities | ||||
| Ethanol/ethyl acetate/water extract | A64-CLS, AN3Ca, Calu-1, GAMG, HNO97, HT29, KATO II, MDA-MB-231, MeWo, PC-3, Sk-Br-3, Sk-OV-3, T24, UACC-62, A549 cell lines | Spain | IC50 ranged between 0.37 ± 0.03 and 4.9 μg/ml; the extract exhibited high selectivity and cytotoxic effect against lung cancer cells A549 |
|
| Crude aqueous extract | MCF-7, NCI-H460, HeLa, HepG2 cell lines | Algeria | IC50 ranged between 98 ± 8 and 307 ± 27 μg/ml |
|
| Ethyl acetate fraction | IC50 ranged between 59 ± 3 and 189 ± 7 μg/ml | |||
| Butanol fraction | IC50 ranged between 76 ± 4 and 209 ± 15 μg/ml | |||
|
| ||||
| Essential oil | Y-maze task, Radial arm maze task | Morocco | The EO vapor at concentrations of 1 and 3% reversed the reduction in Aβ1-42-induced spontaneous alternation, while in the radial arm maze; the inhalation of the EO significantly rectified the working and References memory errors |
|
|
| ||||
| Aqueous extract | DPPH scavenging activity | Algeria | IC50 = 12.7 ± 0.7 μg/ml |
|
| I | IC50 = 12.9 ± 0.1 μg/ml | |||
| Reducing power | ||||
| β-carotene bleaching inhibition | IC50 = 1,180 ± 19 μg/ml | |||
| TBARS inhibition | IC50 = 4.8 ± 0.4 μg/ml | |||
| Aqueous extract | DPPH scavenging activity | Morocco | IC50 = 27.38 ± 0.02 μg/ml |
|
| II. | IC50 = 32.92 ± 0.56 μg/ml | |||
| ABTS | ||||
| FRAP | IC50 = 47.12 ± 0.15 μg/ml | |||
| Essential oil (Hydrodistillation) | DPPH scavenging activity | Algeria | IC50 = 517.65 ± 1.21 μg/ml |
|
| III. | IC50 = 45.12 ± 0.14 μg/ml | |||
| Reducing power | ||||
| Essential oil (Microwave-assisted hydrodistillation) | DPPH scavenging activity | IC50 = 191.72 ± 1.22 μg/ml | ||
| IV. | IC50 = 30.19 ± 0.15 μg/ml | |||
| Reducing power | ||||
|
| ||||
| Aqueous extract | Nitric oxide (NO) production | Algeria | IC50 = 241 ± 4 μg/ml |
|
| Essential oil (Hydrodistillation) | Lipoxygenase inhibition assay | Algeria | IC50 = 72.55 ± 0.14 μg/ml |
|
| V | IC50 = 61.56 ± 0.19 μg/ml | |||
| Xanthine oxidase (XO) inhibition assay | ||||
| Essential oil (Microwave-assisted hydrodistillation) | Lipoxygenase inhibition assay | IC50 = 79.88 ± 0.13 μg/ml | ||
| VI. | IC50 = 74.95 ± 0.15 μg/ml | |||
| Xanthine oxidase (XO) inhibition assay | ||||
|
| ||||
| Essential oil (Cytotoxic activity) | MDA-MB-23, SW620 cell lines | Tunisia | The EO exhibited a cytotoxic effect against both cell lines MDA-MB-23, SW620, with IC50 values of 83.0 and 25.7 μg/ml, respectively |
|
Summary of the antimicrobial potency of T. articulata extracts.
| Extract | Tested strains | Key results | Country | References |
| Sawdust of the root burl | ||||
|
| 09 Strains of | MIC ranging between 0.19 and 48 nL/ml and IZ ranging between 25 and 44 mm ( | Morocco |
|
|
| MIC = 5 μL/ml; Φ mm = 19 |
| ||
|
| MIC = 10 μL/ml; Φ mm = 10 | |||
|
| MIC = 10 μL/ml; Φ mm = 17 | |||
|
| MIC = 10 μL/ml; Φ mm = 13 | |||
|
| MIC = 1.25 μL/ml; MBC = 1.25 µL/ml; Φ mm = 17 |
| ||
|
| MIC = 1.25 μL/ml; MBC = 1.25 µL/ml; Φ mm = 13 | |||
|
| MIC = 1.25 μL/ml; MBC = 1.25 µL/ml; Φ mm = 12 | |||
|
| MIC = 1.25 μL/ml; MBC = 20 µL/ml; Φ mm = 13 | |||
|
| ||||
|
|
| MIC = 2.5 μL/ml; Φ mm = 19.16 ± 0.57 | Morocco |
|
|
| MIC = 80 μL/ml; Φ mm = 6.66 ± 0.76 | |||
|
| MIC = 2.5 μL/ml; Φ mm = 17 ± 0.28 | |||
|
| MIC = 40 μL/ml; Φ mm = 9.26 ± 0.30 | |||
|
| ||||
|
|
| MIC = 7.5 μL/ml; Φ mm = 22 | Algeria |
|
|
| MIC = 5 μL/ml; Φ mm = 60.5 | |||
|
| Φ mm = 1 | |||
|
| MIC = 10 μL/ml; Φ mm = 19 | |||
|
| Φ mm = 1 | |||
|
| Φ mm = 48 ± 00; MIC and MBC = 1.56 ± 0.00 μg/ml | Morocco |
| |
|
| Φ mm = 8 ± 00; MIC and MBC = 25 ± 0.00 μg/ml | |||
|
| Φ mm = 30 ± 00; MIC and MBC = 6.25 ± 0.00 μg/ml | |||
|
| Φ mm = 35 ± 00; MIC and MBC = 6.25 ± 0.00 μg/ml | Morocco |
| |
|
| Φ mm = 7 ± 00; MIC and MBC = 50 ± 0.00 μg/ml | |||
|
| Φ mm = 16 ± 00; MIC and MBC = 6.25 ± 0.00 μg/ml | |||
|
| Φ mm = 7.0 ± 0.1; MIC = 1.0 μg/ml | Algeria |
| |
|
| Φ mm = 7.5 ± 0.2; MIC = 0.4 μg/ml | |||
|
| Φ mm = 22.0 ± 0.9; MIC = 0.2 μg/ml | |||
|
| The EO demonstrated significant mycelial growth inhibition, with | Tunisia |
| |
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
| ||||
|
|
| Φ mm = 10.0 ± 0.2; MIC = 0.4 μg/ml | Algeria |
|
|
| Φ mm = 12.0 ± 0.2; MIC = 0.2 μg/ml | |||
|
| Φ mm = 17.0 ± 0.6; MIC = 0.4 μg/ml | |||
|
|
| Φ mm = 40.00 ± 0.57; MIC = 0.25 ± 0.00 μg/ml | ||
|
| Φ mm = 14.00 ± 0.50; MIC = 15 ± 0.00 μg/ml | |||
|
| Φ mm = 13.00 ± 0.50; MIC = 20 ± 0.00 μg/ml | |||
|
| Φ mm = 12.50 ± 0.29; MIC = 30 ± 0.00 μg/ml | |||
|
| Φ mm = 15.00 ± 0.29; MIC = 10 ± 0.00 μg/ml | |||
|
| Φ mm = 14.50 ± 0.29; MIC = 10 ± 0.00 μg/ml | |||
|
|
| Φ mm = 55.00 ± 1.00; MIC = 0.1 ± 0.0 μg/ml ¥ | ||
|
| Φ mm = 12.50 ± 0.5; MIC = 30 ± 0.00 μg/ml | |||
|
| Φ mm = 12.17 ± 0.50; MIC = 30 ± 0.00 μg/ml ¥ | |||
|
| Φ mm = 12.00 ± 0.16; MIC = 30 ± 0.00 μg/ml ¥ | |||
|
| Φ mm = - | |||
|
| Φ mm = 14.50 ± 0.50; MIC = 10 ± 0.00 μg/ml | |||
|
|
| Φ mm = 42.00 ± 0.66; MIC = 0.25 ± 0.00 μg/ml γ | Algeria |
|
|
| Φ mm = 29.50 ± 0.50; MIC = 0.5 ± 0.00 μg/ml γ | |||
|
| Φ mm = 15.00 ± 0.50; MIC = 10 ± 0.00 μg/ml γ | |||
|
| Φ mm = 14.50 ± 0.50; MIC = 10 ± 0.00 μg/ml γ | |||
|
| Φ mm = 20.00 ± 0.29; MIC = 1 ± 0.00 μg/ml γ | |||
|
| Φ mm = 16.50 ± 0.29; MIC = 5 ± 0.00 μg/ml γ | |||
|
|
| Φ mm = 28.00 ± 0.50; MIC = 0.5 ± 0.00 μg/ML δ | ||
|
| Φ mm = 11.50 ± 0.29; MIC = 40 ± 0.00µg/ml δ | |||
|
| Φ mm = 10.00 ± 0.50; MIC = 50 ± 0.00 µg/ml δ | |||
|
| Φ mm = 10.00 ± 0.50; MIC = 50 ± 0.00µg/ml δ | |||
|
| Φ mm = 12.00 ± 0.50; MIC = 30 ± 0.00µg/ml δ | |||
|
| Φ mm = 11.50 ± 0.50; MIC = 40 ± 0.00µg/ml δ | |||
|
|
| Φ mm = 14.50 ± 0.50; MIC = 10 ± 0.00 µg/ml | ||
|
| Φ mm = 17.50 ± 0.50; MIC = 5 ± 0.00 µg/ml | |||
|
| Φ mm = 13.50 ± 0.50; MIC = 20 ± 0.00 µg/ml | |||
|
| Φ mm = 11.50 ± 0.16; MIC = 40 ± 0.00 µg/ml | |||
|
| Φ mm = 10.50 ± 0.29; MIC = 60 ± 0.00 µg/ml | |||
|
| Φ mm = 12.50 ± 0.50; MIC = 30 ± 0.00 µg/ml | |||
|
| ||||
|
|
| Φ mm = 25; MIC = 268 µg/ml | Algeria |
|
|
| Φ mm = 23; MIC = 268 µg/ml | |||
|
| Φ mm = 25; MIC = 268 µg/ml | |||
|
| Φ mm = 25; MIC = 268 µg/ml | |||
|
| Φ mm = 21; MIC = 516 µg/ml | |||
|
| Φ mm = 23; MIC = 268 µg/ml | |||
|
| ||||
|
|
| Φ mm = 20; MIC = 516 µg/ml | Algeria |
|
|
| Φ mm = 29; MIC = 64,5 µg/ml | |||
|
| Φ mm = 20; MIC = 516 µg/ml | |||
|
| Φ mm = 20; MIC = 516 µg/ml | |||
|
| Φ mm = 23; MIC = 268 µg/ml | |||
|
| Φ mm = 22; MIC = 268 µg/ml | |||
|
| ||||
|
|
| Φ mm = 24.0 ± 4.2 | ||
|
| Φ mm = 38.5 ± 8.2 | |||
|
| Φ mm = 11.7 ± 0.6 | |||
|
| Φ mm = 10.0 ± 0.0 | |||
|
| Φ mm = 6.0 ± 0.0 | |||
|
| Φ mm = 6.0 ± 0.0 | |||
|
| Φ mm = 12. ±1.2 | |||
|
| Φ mm = 19.0 ± 1.0 | |||
|
| Φ mm = 13.0 ± 1.7 | |||
|
| Φ mm = - | |||
|
|
| Φ mm = 20.0 ± 1.7 | Algeria |
|
|
| Φ mm = 24.0 ± 1.4 | |||
|
| Φ mm = 15.3 ± 1.2 | |||
|
| Φ mm = 11.3 ± 0.6 | |||
|
| Φ mm = 6.0 ± 0.0 | |||
|
| Φ mm = 6.0 ± 0.0 | |||
|
| Φ mm = 15.0 ± 0.0 | |||
|
| Φ mm = 11.3 ± 0.6 | |||
|
| Φ mm = 8.3 ± 0.6 | |||
|
| Φ mm = 21.3 ± 4.2 | |||
|
|
| Φ mm = 20.0 ± 1.7 | ||
|
| Φ mm = 24.6 ± 0.9 | |||
|
| Φ mm = 9.3 ± 0.6 | |||
|
| Φ mm = 6.0 ± 0,0 | |||
|
| Φ mm = 6.0 ± 0.0 | |||
|
| Φ mm = 6.0 ± 0.0 | |||
|
| Φ mm = 12.0 ± 0.0 | |||
|
| Φ mm = 11.7 ± 1.2 | |||
|
| Φ mm = 12.7 ± 2.1 | |||
|
| Φ mm = 20.0 ± 5.3 | |||
S : The sample was dominated by camphor (33.7%) as the major constituent; S : The sample was characterized by a high content of α-pinene (50.2%); S : Bornyl acetate (42.5%) was the main compound in the sample.
¥, γ, δ exhibited antagonism, synergism and partial synergism effects with Amox, respectively.
Biocidal properties of T. articulata-based extracts.
| Extracts | Pests controlled | Mode of preparation and application | Key results | References |
|---|---|---|---|---|
| EO (at different phenological stages) |
| The pulverization of essential oil as preventive treatment on detached tomato leaflets | The EO at the concentration of 2 mg/ml prevents symptoms of alteration and reduces the infection of |
|
| EO |
| The EO was applied topically on the dorsal thorax of aphids |
|
|
| MeOH extract |
| The insecticidal effect was assessed using contact toxicity (Whatman paper was impregnated with different doses, then placed in a Petri dish with 20 insects) | The extract was highly toxic and caused mortality of 95.65% after 24 h at a dose of 60 mg/cm2 |
|
| Wood aqueous extract |
| Acute and reprotoxicity of the aqueous extracts (from 0.5 mg/L to 17 mg/L) was assessed on freshwater cladoceran | The extract at various concentrations exhibited significant acute toxicity and reprotoxicity on |
|
Patents related to T. articulata published between 2001 and 2022.
| Patent number | Title | Issue date | Description of the invention | References |
|---|---|---|---|---|
| US11357246 | High intensity sweeteners | 2022-01-14 | The patent relates to the fields of foods, chemistry, beverages, and other edible components. It focuses on sweet-tasting compounds, sweet taste enhancers, and combinations thereof for ingestible compositions such as beverages, foods, as well as other orally delivered therapeutic products |
|
| JP2021104190 | Space adjustment device and space adjustment method | 2021-07-26 | A space-adjusting device comprising 14 medicinal plants releases volatile components acting on a |
|
| US10337139 | Combination of an organic substrate and organic formulation for use as a cutting board and storage container | 2019-07-02 | A formulation consisting of bees wax and |
|
| US20170143022 | Compositions Incorporating an Umami Flavor Agent | 2017-04-25 | The present invention relates to formulations consisting of an Umami flavor agent in combination with one or more other food additives, suitably derived from herb, spice, fat, or oil to improve sweeteners, bittering agents, acid/sour flavor agents, or salts |
|
| US20170096418 | Compounds useful as modulators of TRPM8 | 2017-04-06 | The present invention relates to compounds beneficial as cooling agents, which are capable of modulating Melastatin Transient Receptor Potential Channel 8 (TRPM8) involved in the chemesthetic sensation to generate a cooling effect |
|
| US20150246087 | Extracts and therapeutic uses thereof | 2015-09-03 | A |
|
| US20110311661 | Plant extracts and dermatological uses thereof | 2011-12-22 | The invention relates to dermatology, wherein dermatological formulations from plant extracts (at least one plant, including |
|
| US20100292193 | Radioprotective drugs | 2010-11-18 | The invention relates to a method consisting of the administration of cyclopiazonic acid (CPA) and/or a cyclopiazonic acid derivative to a subject to reduce radiation damage to tissues or cells during radiotherapy |
|
| US20070299046 | Orally available light-independent antineoplastic compounds | 2007-12-27 | The patent claims the capacity of the pheophorbide derivative compounds from plants to inhibit cell proliferation and angiogenesis | ( |
| US20060228426 | Plant extracts for treatment of angiogenesis and metastasis | 2006-10-12 | The invention relates to modulators of cellular activity, which consists of plant extracts from several plants, including T. articulata, capable of inhibiting, slowing down, or preventing cell migration such as neoplastic cells |
|
| JP2001220312 | Cosmetic composition containing steam distillate of plant | 2001-08-14 | The invention relates to the cosmetic field. Indeed, several plants from different families, including | ( |